Jean Francois Formela - Mar 30, 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Ommer Chohan, as Attorney-in-Fact for Jean Francois Formela
Stock symbol
IKNA
Transactions as of
Mar 30, 2021
Transactions value $
$1,614,428
Form type
4
Date filed
12/14/2021, 07:29 PM
Next filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKNA Common Stock Purchase $2M +125K +16.67% $16.00 875K Mar 30, 2021 See footnote F1
transaction IKNA Common Stock Sale -$180K -12K -0.95% $15.03 1.26M Dec 10, 2021 See footnote F2, F3
transaction IKNA Common Stock Sale -$122K -8.33K -0.66% $14.64 1.25M Dec 13, 2021 See footnote F3, F4
transaction IKNA Common Stock Sale -$83.4K -5.96K -0.48% $14.00 1.24M Dec 14, 2021 See footnote F3
holding IKNA Common Stock 2.9M Mar 30, 2021 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $15.55 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
F3 The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of Associates XI LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.65 inclusive.
F5 These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). Atlas Venture Associates X, L.P. ("AVA X LP") is the general partner of Atlas Venture Fund X. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.